Multimodal Assesment of Alzheimer Patients
NCT: NCT06448403 · RECRUITING
Brief Summary
The goal of this study is to learn more about the changes in the brains of patients with cognitive impairment (MCI) and Alzheimer's Disease (AD). The main questions the study aims to answer are: 1. What findings can be used to earlier detect patients that will develop Alzheimers? 2. Which differences are seen between healthy and cognitively impaired patients? 3. Which differences are seen between patients with Alzheimers disease? Participants will undergo: * Cognitive tests * Magnetic resonance imaging (MRI) * Electroencephalography (EEG) * Blood sample collection * Fecal sample collection * A randomized group will undergo polysomnography analysis.
Frequently Asked Questions
What is Multimodal Assesment of Alzheimer Patients?
Multimodal Assesment of Alzheimer Patients is a clinical trial registered under NCT06448403. Current status: RECRUITING.
What is the status of NCT06448403?
The current status of NCT06448403 (Multimodal Assesment of Alzheimer Patients) is: RECRUITING.
When did Multimodal Assesment of Alzheimer Patients start?
Multimodal Assesment of Alzheimer Patients started on 2024-07-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.